📣 #ESMOBreast26: Each year, more and more abstracts shape the scientific discussions at this meeting – make sure your work is part of the conversation.
⏰ Submit your abstract by 27 January 2026
🔗 https://ow.ly/NVfo50XofUU
#esmomeetings
⏰ Submit your abstract by 27 January 2026
🔗 https://ow.ly/NVfo50XofUU
#esmomeetings
November 19, 2025 at 8:00 AM
📣 #ESMOBreast26: Each year, more and more abstracts shape the scientific discussions at this meeting – make sure your work is part of the conversation.
⏰ Submit your abstract by 27 January 2026
🔗 https://ow.ly/NVfo50XofUU
#esmomeetings
⏰ Submit your abstract by 27 January 2026
🔗 https://ow.ly/NVfo50XofUU
#esmomeetings
📣 #ESMOBreast26: One week left to share your studies! The field of breast cancer research is advancing rapidly — and your work can help shape the next breakthroughs.
⏰ Deadline: 27 January 2026
🔗 https://ow.ly/ieY350XX7b1
#esmomeetings
⏰ Deadline: 27 January 2026
🔗 https://ow.ly/ieY350XX7b1
#esmomeetings
January 19, 2026 at 6:00 AM
📣 #ESMOBreast26: One week left to share your studies! The field of breast cancer research is advancing rapidly — and your work can help shape the next breakthroughs.
⏰ Deadline: 27 January 2026
🔗 https://ow.ly/ieY350XX7b1
#esmomeetings
⏰ Deadline: 27 January 2026
🔗 https://ow.ly/ieY350XX7b1
#esmomeetings
📣 #ESMOBreast26 is more than a meeting: it’s an educational hub where your research connects with practice to spark new collaborations.
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 https://ow.ly/tVP450XpQbk
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 https://ow.ly/tVP450XpQbk
December 17, 2025 at 9:00 AM
📣 #ESMOBreast26 is more than a meeting: it’s an educational hub where your research connects with practice to spark new collaborations.
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 https://ow.ly/tVP450XpQbk
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 https://ow.ly/tVP450XpQbk
📣 #ESMOBreast26: Last days to share your research! Gain unparalleled visibility by presenting your work to clinicians, researchers, and decision-makers from across the globe.
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 buff.ly/gpGvyJI
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 buff.ly/gpGvyJI
January 7, 2026 at 10:03 AM
📣 #ESMOBreast26: Last days to share your research! Gain unparalleled visibility by presenting your work to clinicians, researchers, and decision-makers from across the globe.
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 buff.ly/gpGvyJI
⏰ Submit your abstract by 27 January 2026
#esmomeetings
🔗 buff.ly/gpGvyJI
📣 #ESMOBreast26: Last 24 hours to share your studies! Contribute to a meeting recognised for its scientific depth and commitment to advancing breast cancer care. Don’t wait—submit now!
⏰ Deadline: 27 January 2026
#esmomeetings
🔗 buff.ly/hOEmpXL
⏰ Deadline: 27 January 2026
#esmomeetings
🔗 buff.ly/hOEmpXL
January 26, 2026 at 6:31 AM
📣 #ESMOBreast26: Last 24 hours to share your studies! Contribute to a meeting recognised for its scientific depth and commitment to advancing breast cancer care. Don’t wait—submit now!
⏰ Deadline: 27 January 2026
#esmomeetings
🔗 buff.ly/hOEmpXL
⏰ Deadline: 27 January 2026
#esmomeetings
🔗 buff.ly/hOEmpXL
📣 #ESMOBreast26: An event to advance knowledge across the entire spectrum of breast oncology, where cutting-edge science, networking and innovation await.
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/vREN50Y5goF
#esmomeetings
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/vREN50Y5goF
#esmomeetings
January 30, 2026 at 6:30 AM
📣 #ESMOBreast26: An event to advance knowledge across the entire spectrum of breast oncology, where cutting-edge science, networking and innovation await.
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/vREN50Y5goF
#esmomeetings
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/vREN50Y5goF
#esmomeetings
📣 #ESMOBreast26: Are you ready to have a global impact in breast cancer research?
Submit your abstract and be part of the change! Your contribution will be key to driving progress and advancing patient care worldwide.
⏰ Deadline 27 January 2026
🔗 buff.ly/RsJQP6s
Submit your abstract and be part of the change! Your contribution will be key to driving progress and advancing patient care worldwide.
⏰ Deadline 27 January 2026
🔗 buff.ly/RsJQP6s
September 18, 2025 at 9:30 AM
📣 #ESMOBreast26: Are you ready to have a global impact in breast cancer research?
Submit your abstract and be part of the change! Your contribution will be key to driving progress and advancing patient care worldwide.
⏰ Deadline 27 January 2026
🔗 buff.ly/RsJQP6s
Submit your abstract and be part of the change! Your contribution will be key to driving progress and advancing patient care worldwide.
⏰ Deadline 27 January 2026
🔗 buff.ly/RsJQP6s
📣 #ESMOBreast26: Contribute to the collective effort of shaping the future of breast cancer treatment and care. #esmomeetings
⏰ Submit your abstract by 27 January 2026.
🔗 https://ow.ly/7Txb50X7yVw
⏰ Submit your abstract by 27 January 2026.
🔗 https://ow.ly/7Txb50X7yVw
October 15, 2025 at 9:30 AM
📣 #ESMOBreast26: Contribute to the collective effort of shaping the future of breast cancer treatment and care. #esmomeetings
⏰ Submit your abstract by 27 January 2026.
🔗 https://ow.ly/7Txb50X7yVw
⏰ Submit your abstract by 27 January 2026.
🔗 https://ow.ly/7Txb50X7yVw
#ESMOBreast26: In TROPION-Breast02, datopotamab deruxtecan (Dato-DXd) showed sustained patient-reported outcome improvements alongside survival benefits in advanced #TNBC.
#ESMODailyReporter https://ow.ly/b2gg50YYHqS
#ESMODailyReporter https://ow.ly/b2gg50YYHqS
May 15, 2026 at 8:15 AM
#ESMOBreast26: In TROPION-Breast02, datopotamab deruxtecan (Dato-DXd) showed sustained patient-reported outcome improvements alongside survival benefits in advanced #TNBC.
#ESMODailyReporter https://ow.ly/b2gg50YYHqS
#ESMODailyReporter https://ow.ly/b2gg50YYHqS
Biomarker analyses indicate that CD47 expression may help predict benefit from zanidatamab plus evorpacept in HER2-positive metastatic breast cancer. @myesmo.bsky.social #ESMOBreast26 #bcsm #oncology
www.onclive.com/view/cd47-ex...
www.onclive.com/view/cd47-ex...
May 21, 2026 at 2:51 PM
Biomarker analyses indicate that CD47 expression may help predict benefit from zanidatamab plus evorpacept in HER2-positive metastatic breast cancer. @myesmo.bsky.social #ESMOBreast26 #bcsm #oncology
www.onclive.com/view/cd47-ex...
www.onclive.com/view/cd47-ex...
📣 #ESMOBreast26: The place to gain exclusive insights into the latest advancements in breast cancer treatment and care.
⏰ Last days to benefit from big savings! Deadline 26 February 2026
🔗 https://ow.ly/bvt450YccxW
#esmomeetings
⏰ Last days to benefit from big savings! Deadline 26 February 2026
🔗 https://ow.ly/bvt450YccxW
#esmomeetings
February 19, 2026 at 6:30 AM
📣 #ESMOBreast26: The place to gain exclusive insights into the latest advancements in breast cancer treatment and care.
⏰ Last days to benefit from big savings! Deadline 26 February 2026
🔗 https://ow.ly/bvt450YccxW
#esmomeetings
⏰ Last days to benefit from big savings! Deadline 26 February 2026
🔗 https://ow.ly/bvt450YccxW
#esmomeetings
📣 #ESMOBreast26: Collaborations between experts of different countries and areas of expertise, excellent networking opportunities and the latest science and education.
⏰Register by 8 April for advantageous fees.
🔗 https://ow.ly/GbBk50YrNVY
#esmomeetings
⏰Register by 8 April for advantageous fees.
🔗 https://ow.ly/GbBk50YrNVY
#esmomeetings
March 11, 2026 at 9:00 AM
📣 #ESMOBreast26: Collaborations between experts of different countries and areas of expertise, excellent networking opportunities and the latest science and education.
⏰Register by 8 April for advantageous fees.
🔗 https://ow.ly/GbBk50YrNVY
#esmomeetings
⏰Register by 8 April for advantageous fees.
🔗 https://ow.ly/GbBk50YrNVY
#esmomeetings
📣 #ESMOBreast26: Get inspired and be part of the conversation shaping the future of breast cancer treatment and care. Last chance to register and save!
⏰ Deadline 26 February 2026
🔗 https://ow.ly/8RGA50YlJQm
#esmomeetings
⏰ Deadline 26 February 2026
🔗 https://ow.ly/8RGA50YlJQm
#esmomeetings
February 25, 2026 at 2:02 PM
📣 #ESMOBreast26: Get inspired and be part of the conversation shaping the future of breast cancer treatment and care. Last chance to register and save!
⏰ Deadline 26 February 2026
🔗 https://ow.ly/8RGA50YlJQm
#esmomeetings
⏰ Deadline 26 February 2026
🔗 https://ow.ly/8RGA50YlJQm
#esmomeetings
Daniel F. Hayes is the recipient of the 2026 ESMO Breast Cancer Award in recognition of his contributions to the #BreastCancer field, particularly in experimental therapeutics & #CancerBiomarkers. He will deliver his award lecture on 6 May at #ESMOBreast26.
📌 https://ow.ly/QwN250YBFs6
📌 https://ow.ly/QwN250YBFs6
April 7, 2026 at 8:00 AM
Daniel F. Hayes is the recipient of the 2026 ESMO Breast Cancer Award in recognition of his contributions to the #BreastCancer field, particularly in experimental therapeutics & #CancerBiomarkers. He will deliver his award lecture on 6 May at #ESMOBreast26.
📌 https://ow.ly/QwN250YBFs6
📌 https://ow.ly/QwN250YBFs6
📣 #ESMOBreast26: Late-breaking abstract titles are online! Browse the programme to see the exciting science you can look forward to and register now before it’s too late!
🔗 https://ow.ly/Xf9K50YJVnI
See you in Berlin and online.
#esmomeetings
🔗 https://ow.ly/Xf9K50YJVnI
See you in Berlin and online.
#esmomeetings
April 20, 2026 at 7:00 AM
📣 #ESMOBreast26: Late-breaking abstract titles are online! Browse the programme to see the exciting science you can look forward to and register now before it’s too late!
🔗 https://ow.ly/Xf9K50YJVnI
See you in Berlin and online.
#esmomeetings
🔗 https://ow.ly/Xf9K50YJVnI
See you in Berlin and online.
#esmomeetings
📣 #ESMOBreast26: Join global experts in Berlin, and online, to explore cutting-edge research in breast cancer care – registration system now open!
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/seSv50XMxzn
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/seSv50XMxzn
December 29, 2025 at 8:30 AM
📣 #ESMOBreast26: Join global experts in Berlin, and online, to explore cutting-edge research in breast cancer care – registration system now open!
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/seSv50XMxzn
⏰ Benefit from big savings if you register before 26 February 2026
🔗 https://ow.ly/seSv50XMxzn
#ESMOBreast26 was a space for collaboration, meaningful conversations, and shared purpose. Over these days in Berlin, researchers, clinicians, partners, and advocates came together with one common goal: advancing breast cancer research and improving patients’ lives.
May 22, 2026 at 7:31 AM
#ESMOBreast26 was a space for collaboration, meaningful conversations, and shared purpose. Over these days in Berlin, researchers, clinicians, partners, and advocates came together with one common goal: advancing breast cancer research and improving patients’ lives.
#ESMOBreast26 Award recipient Daniel F. Hayes, describes how his career was shaped by milestone discoveries in #BreastCancer and how #Biomarker research is evolving treatment with promising new #CancerTherapies. Read more
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
May 6, 2026 at 11:30 AM
#ESMOBreast26 Award recipient Daniel F. Hayes, describes how his career was shaped by milestone discoveries in #BreastCancer and how #Biomarker research is evolving treatment with promising new #CancerTherapies. Read more
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
#ESMODailyReporter 🔗 https://ow.ly/9GqE50YVtVC
📣 #ESMOBreast26: Final call for registration savings! Don’t miss your opportunity to join a global community of breast cancer experts, exchange insights and shape the future of patient care
⏰ Early registration deadline: 8 April at 23:59 CEST
🔗 https://ow.ly/wY7n50YCNNh
#esmomeetings
⏰ Early registration deadline: 8 April at 23:59 CEST
🔗 https://ow.ly/wY7n50YCNNh
#esmomeetings
April 7, 2026 at 9:00 AM
📣 #ESMOBreast26: Final call for registration savings! Don’t miss your opportunity to join a global community of breast cancer experts, exchange insights and shape the future of patient care
⏰ Early registration deadline: 8 April at 23:59 CEST
🔗 https://ow.ly/wY7n50YCNNh
#esmomeetings
⏰ Early registration deadline: 8 April at 23:59 CEST
🔗 https://ow.ly/wY7n50YCNNh
#esmomeetings
📢 Call for #YoungOncologists & Trainees.
Submit your clinical case for a chance to present at #ESMOBreast26.
Topics:
✔ De-escalating treatment in early-stage BC
✔ Lobular breast cancer
✔ Biomarkers for treating TNBC
📅 Deadline: 22 March 2026
🔗 https://ow.ly/F0Bc50YrH0h
Submit your clinical case for a chance to present at #ESMOBreast26.
Topics:
✔ De-escalating treatment in early-stage BC
✔ Lobular breast cancer
✔ Biomarkers for treating TNBC
📅 Deadline: 22 March 2026
🔗 https://ow.ly/F0Bc50YrH0h
March 10, 2026 at 11:30 AM
📢 Call for #YoungOncologists & Trainees.
Submit your clinical case for a chance to present at #ESMOBreast26.
Topics:
✔ De-escalating treatment in early-stage BC
✔ Lobular breast cancer
✔ Biomarkers for treating TNBC
📅 Deadline: 22 March 2026
🔗 https://ow.ly/F0Bc50YrH0h
Submit your clinical case for a chance to present at #ESMOBreast26.
Topics:
✔ De-escalating treatment in early-stage BC
✔ Lobular breast cancer
✔ Biomarkers for treating TNBC
📅 Deadline: 22 March 2026
🔗 https://ow.ly/F0Bc50YrH0h
#ESMOBreast26: #ClinicalResearch should include #PatientCentred factors, such as impact on fertility. In the #ESMODailyReporter, Matteo Lambertini highlights strategies to tailor therapy without compromising efficacy, safety and #QoL. Read the editorial ➡️ https://ow.ly/IZPr50YVzvs
May 6, 2026 at 4:02 PM
#ESMOBreast26: #ClinicalResearch should include #PatientCentred factors, such as impact on fertility. In the #ESMODailyReporter, Matteo Lambertini highlights strategies to tailor therapy without compromising efficacy, safety and #QoL. Read the editorial ➡️ https://ow.ly/IZPr50YVzvs
Our May cover highlights an analysis of data from the Breast Cancer Association Consortium, looking at mammographic density, gene variants, and #breastcancer risk
The paper is Open Access: www.thelancet.com/journals/lan...
#ESMOBreast26 @cam.ac.uk @ki.se @cancerresearchuk.org @nihr.bsky.social
The paper is Open Access: www.thelancet.com/journals/lan...
#ESMOBreast26 @cam.ac.uk @ki.se @cancerresearchuk.org @nihr.bsky.social
May 8, 2026 at 7:47 AM
Our May cover highlights an analysis of data from the Breast Cancer Association Consortium, looking at mammographic density, gene variants, and #breastcancer risk
The paper is Open Access: www.thelancet.com/journals/lan...
#ESMOBreast26 @cam.ac.uk @ki.se @cancerresearchuk.org @nihr.bsky.social
The paper is Open Access: www.thelancet.com/journals/lan...
#ESMOBreast26 @cam.ac.uk @ki.se @cancerresearchuk.org @nihr.bsky.social
A Truly Global Dana-Farber Representation at ESMO Breast 2026 - Paolo Tarantino
@ptarantinomd.bsky.social @danafarber.bsky.social
oncodaily.com/voices/paolo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOBreast26
@ptarantinomd.bsky.social @danafarber.bsky.social
oncodaily.com/voices/paolo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOBreast26
Paolo Tarantino: A Truly Global Dana-Farber Representation at ESMO Breast 2026 - OncoDaily
Paolo Tarantino: A Truly Global Dana-Farber Representation at ESMO Breast 2026 / Breast Cancer, cancer, Dana-Farber’s Breast Oncology Center, OncoDaily,
oncodaily.com
May 11, 2026 at 11:12 AM
A Truly Global Dana-Farber Representation at ESMO Breast 2026 - Paolo Tarantino
@ptarantinomd.bsky.social @danafarber.bsky.social
oncodaily.com/voices/paolo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOBreast26
@ptarantinomd.bsky.social @danafarber.bsky.social
oncodaily.com/voices/paolo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOBreast26
ESMO Breast 2026 Momentum In Breast Cancer Research Is Hard To Ignore - Olubukola Ayodele
@myesmo.bsky.social @bookiephronesis.bsky.social
oncodaily.com/voices/olubu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer #ESMOBreast26
@myesmo.bsky.social @bookiephronesis.bsky.social
oncodaily.com/voices/olubu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer #ESMOBreast26
Olubukola Ayodele: ESMO Breast 2026 Momentum In Breast Cancer Research Is Hard To Ignore - OncoDaily
Olubukola Ayodele: ESMO Breast 2026 Momentum In Breast Cancer Research Is Hard To Ignore / Breast Cancer, cancer, ESMO Breast 2026, Olubukola Ayodele,
oncodaily.com
May 4, 2026 at 4:11 PM
ESMO Breast 2026 Momentum In Breast Cancer Research Is Hard To Ignore - Olubukola Ayodele
@myesmo.bsky.social @bookiephronesis.bsky.social
oncodaily.com/voices/olubu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer #ESMOBreast26
@myesmo.bsky.social @bookiephronesis.bsky.social
oncodaily.com/voices/olubu...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer #ESMOBreast26
Dear Colleages, This Survey aims to better understand current clinical practices and perspectives regarding the use of adjuvant CDK4/6 inhibitors in early-stage HR+/HER2− #BreastCancer . Participate Here 👉 app2.tedme.com?pin=Adjuvant...
#ESMOBreast26
#ESMOBreast26
May 7, 2026 at 1:19 PM
Dear Colleages, This Survey aims to better understand current clinical practices and perspectives regarding the use of adjuvant CDK4/6 inhibitors in early-stage HR+/HER2− #BreastCancer . Participate Here 👉 app2.tedme.com?pin=Adjuvant...
#ESMOBreast26
#ESMOBreast26